Search
-
European Observatory of Rare Diseases reveals that Europeans find conditions for patients with rare diseases are unacceptable
ASAP FOR CHILDREN has published the results of its third European Rare Disease Observatory conducted by Ipsos.
-
What Worries the World – November 2024
Conducted monthly in 29 countries among 20,000 adults for over a decade, the Ipsos What Worries the World study offers an exceptional snapshot of world opinion on pressing global issues.
-
Ipsos Update - November 2024
Mental Health, AI, Infrastructure … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
The Women’s Forum for the Economy & Society unveils its 2024 Barometer, in partnership with Ipsos
On the occasion of the 19th edition of its Global Meeting, the Women’s Forum reveals the results of its annual barometer on gender inequalities, developed in partnership with Ipsos, among a sample of 3,500 people residing within the countries of the G7.
-
The Forces Reshaping the World's Attitudes: Navigating Uncertainty in Switzerland and Beyond
This year as we unveil the Ipsos Global Trends, we have collaborated with Handelszeitung in the scope of providing key insights.
-
What Worries the World – October 2024
Conducted monthly in 29 countries among 20,000 adults for over a decade, the Ipsos What Worries the World study offers an exceptional snapshot of world opinion on pressing global issues.
-
Ipsos Update - October 2024
Trends, News, Ageing … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Ipsos World Mental Health Day Report
Younger people (particularly young women) are the most likely to feel depressed and take time off work due to stress according to an Ipsos report for World Mental Health Day 2024
-
Predicting Opportunity in Emerging Therapies
The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.